Repurposed ALS (amyotrophic lateral sclerosis) drug may help slow down a rare genetic disorder in children and adolescents.

‘Riluzole, a repurposed ALS (amyotrophic lateral sclerosis) drug may help slow down a rare genetic disorder called Niemann-Pick disease type C1 (NPC1 – characterized by the gradual loss of a particular brain cell) in children and adolescents.
’

The present study found that on treating the NPC1 mice riluzole, there was an improved survival of 12% longer as compared to untreated mice. 




This showed that riluzole or similar drugs may help slow down the disease progression in NPC1patients.
Source-Medindia